Recent independent assessments of the European HealthTech M&A boutique landscape place Nelson Advisors among the specialist boutiques operating in the $25M–$500M deal range, alongside a small group of firms distinguished by proprietary methodology and deep domain expertise.

This Translation Gap has become a significant liability as healthcare assets have grown in technological and clinical complexity. The clinical software, surgical robotics and interoperable data stacks of the modern market exceed the analytical capabilities of generalist finance. To bridge this linguistic and valuation mismatch, the "Founder Banker" has emerged as a critical class of advisor. These individuals are former entrepreneurs or clinicians who have personally built,

The European medical technology landscape is undergoing a profound paradigm shift driven by the convergence of computational neuroscience, microelectronics, and advanced materials science. At the forefront of this transformation is neuromuscular electrical stimulation (NMES) and its closely related sibling, functional electrical stimulation (FES). Historically confined to clinical environments as analog, open-loop, and manually operated rehabilitation modalities, modern NMES

The healthcare technology (HealthTech) sector has transitioned from a phase of greenfield venture formation to one characterized by rapid platform consolidation. Driven by post-pandemic market corrections, rising operational costs, and regulatory evolution, strategic corporate buyers and private equity sponsors are executing aggressive platform strategies and buy-and-build consolidation programs.